Trastunix
Generic Name : Trastuzumab Indications Adjuvant Breast Cancer: Trastunix is indicated for adjuvant treatment of HER2 overexpressing node-positive or node-negative ER/PR negative or with one high-risk feature breast cancer Metastatic Breast Cancer: Trastunix is indicated: Metastatic Gastric Cancer: Trastunix is indicated, in combination with cisplatin andcapecitabine or 5-fluorouracil, for the treatment of patients with HER2-overexpressingmetastatic […]